Drug treatment based on pharmacogenomics, already a significant factor in oncology, psychiatry, pain management and anticoagulation therapy, is poised to play an important role in transplant medicine, a leading pharmacogenomics expert noted during a session at the 2020 virtual annual meeting of the American College of Clinical Pharmacy.
The Clinical Pharmacogenetics Implementation Consortium (CPIC), an international consortium that writes peer-reviewed, evidence-based gene?drug interaction